Amneal Pharmaceuticals, Inc. (AMRX) News

Amneal Pharmaceuticals, Inc. (AMRX): $2.54

0.11 (+4.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter AMRX News Items

AMRX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AMRX News Highlights

  • For AMRX, its 30 day story count is now at 10.
  • Over the past 21 days, the trend for AMRX's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about AMRX are DECK, DRUG and ICPT.

Latest AMRX News From Around the Web

Below are the latest news stories about AMNEAL PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMRX as an investment opportunity.

Amneal to Report Fourth Quarter and Full Year 2022 Results on March 2, 2023

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its fourth quarter and full year 2022 financial results on Thursday March 2, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on March 2, 2023. The financial results and live webcast will be accessible through the Investor Relations section of the Company''s website at https://invest

Business Wire | January 31, 2023

Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years

Intercept reached a settlement with Amneal that delays a generic version of its only product. In response, ICPT stock surged Wednesday.

Yahoo | January 25, 2023

Amneal Pharmaceuticals Inc. (NYSE: AMRX): The Metrics That Matter Right Now

Amneal Pharmaceuticals Inc. (NYSE:AMRX) price on Friday, January 13, fall -0.45% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.22. A look at the stock’s price movement, the close in the last trading session was $2.23, moving within a range at $2.18 and $2.265. The beta value … Amneal Pharmaceuticals Inc. (NYSE: AMRX): The Metrics That Matter Right Now Read More »

Stocks Register | January 14, 2023

US Releases Stockpiled Tamiflu Supplies Amid Cold, Flu Treatment Shortages

(Bloomberg) -- US health officials have released supplies of the flu drug Tamiflu from a national stockpile as shortages of cold and respiratory medications persist nationwide.Most Read from BloombergElon Musk Fan With 2,900% Gain Sees $1.5 Million Wiped AwayUS Inflation Cools Again, Putting Fed on Track to DownshiftT-Mobile Considers Buying Ryan Reynolds’s Mint MobileThe Document That Separates Biden and TrumpGoogle, Nvidia Express Concerns to FTC About Microsoft’s Activision DealMore than 52,0

Yahoo | January 12, 2023

Amneal Pharmaceuticals (AMRX) presents at 41st Annual J.P. Morgan Healthcare Conference - Slideshow (NYSE:AMRX)

The following slide deck was published by Amneal Pharmaceuticals, Inc.

Seeking Alpha | January 11, 2023

AMRX stock on watch as Amneal Pharma reaffirms guidance (NYSE:AMRX)

Generic drugmaker Amneal Pharmaceuticals (AMRX) reiterated its previously issued financial guidance for the year ending December 31, 2022, on Tuesday. Read the full story here.

Seeking Alpha | January 10, 2023

Amneal joins hands with Orion to commercialize generic products in Europe and more countries

Amneal Pharmaceuticals (AMRX) has signed a long-term license agreement with Orion Corporation to commercialize a number of complex generic products.Under the partnership agreement, Orion…

Seeking Alpha | January 4, 2023

Amneal Announces Strategic European Partnership with Orion Corporation

BRIDGEWATER, N.J., January 04, 2023--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced it has signed a long-term license agreement with Orion Corporation (OMXH: ORNBV & ORNAV) to commercialize a number of Amneal’s complex generic products.

Yahoo | January 4, 2023

At What Point In Time Would I Choose To Purchase Amneal Pharmaceuticals Inc. (NYSE: AMRX) Stock?

The trading price of Amneal Pharmaceuticals Inc. (NYSE:AMRX) closed higher on Friday, December 23, closing at $2.20, 0.92% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $2.17 and $2.25. In examining the 52-week price action we see that the stock hit a 52-week … At What Point In Time Would I Choose To Purchase Amneal Pharmaceuticals Inc. (NYSE: AMRX) Stock? Read More »

Stocks Register | December 27, 2022

Amneal Pharmaceuticals Inc. (NYSE:AMRX) Shares In 2022: Bullish Prospects

Amneal Pharmaceuticals Inc. (NYSE:AMRX) price on Wednesday, December 21, rose 5.24% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.21. A look at the stock’s price movement, the close in the last trading session was $2.10, moving within a range at $2.12 and $2.21. The beta value … Amneal Pharmaceuticals Inc. (NYSE:AMRX) Shares In 2022: Bullish Prospects Read More »

Stocks Register | December 22, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6727 seconds.